January 9, 2014 | Israeli pharmaceutical giant Teva Pharmaceutical Industries has made an offer to acquire American biotechnology company NuPathe for $149 million. NuPathe is developing treatments for various neurological disorders and has a market cap of $100 million.
Subscribe to NoCamels weekly newsletter and get our top stories
Facebook comments